Table 4.
Review of literature in the last two decades: retinotomy in the management of rhegmatogenous retinal detachment with advanced proliferative vitreoretinopathy
| Trial (first author, year, location) | Eyes (patients) | Months of follow-up (range) | Age, year (range); male (%) | PVR classification | SB procedure, n (%) | Type of tamponade, n (%) | Anatomical success rate after first retinotomy surgery, n (%) | Final anatomical success rate, n (%) | Major intraoperative complications, n (%) |
|---|---|---|---|---|---|---|---|---|---|
| Naz et al., 2018, Pakistan4 | 40 (40) | 6 (6-24) | 51.5 (18-65); 72.5 | CP: 36 (90.0) CA: 4 (10.0) | 0 (0) | SO: 40 (100) | 29 (72.5) | 39 (97.5) | Not reported |
| Adhi, 2017, Pakistan19 | 370 (337) | 39 (6-168) | 42 (5-85); 66.8 | CP: 126 (34.1) CA: 244 (65.9) | 90 (24.3) | SO: 302 (81.6) Gas: 68 (18.4) | 311 (84.1) | 344 (93.0) | Intraoperative bleeding: 80 (21.6) Iatrogenic retinal breaks: 48 (13.0) |
| Hocaoglu, 2016, Turkey27 | 24 (24) | 51.5 (6-152) | 44.2 (19-72); 68 | The details was not mentioned | Prior: 5 (20.8) Simultaneous: 4 (16.7) | SO: 24 (100) | Not reported | 19 (79.2) | Not reported |
| Garnier, 2013, France18 | 20 (20) | 58 (25-78) | 38 (18-53); 85 | CA: 20 (100) | Prior: 9 (45.0) Simultaneous: 0 (0) | SO: 20 (100) | Not reported | 14 (70.0) | Not reported |
| Kimura, 2012, Japan17 | 19 (19) | 41 (7-64) | 44.6 (11-73); 52.6 | CP: 3 (15.8) CA: 16 (84.2) | Prior: 5 (26.3) Simultaneous: 11 (57.9) | SO: 19 (100) | 15 (78.9) | 19 (100) | Not reported |
| Shalaby, 2010, Egypt/Saudi Arabia3 | 38 (38) | 20.6 (6-29) | 56.6 (18-76); 52.6 | CP: 18 (47) CA: 26 (68.4) | Prior: 10 (26.3) Simultaneous: 15 (39.5) | SO: 25 (65.8), SF6: 3 (7.9) C3F8: 10 (26.3) | 29 (76.3) | 34 (89.5) | Intraoperative bleeding: 10 (26.3) Iatrogenic retinal breaks: 9 (23.7) |
| Tsui, 2009, US21 | 41 (41) | 37 (6-126) | 62 (20-78); 44.0 | CA: 41 (100) | Prior: 39 (95.1) Simultaneous: 2 (4.9) | SO: 41 (100) | Not reported | 37 (90.2) | Not reported |
| Lim, 2009, Malaysia28 | 30 (30) | 6 | 58.5 (28-86); 63.3 | CP and CA: The details was not mentioned | Prior: The details of prior surgeries was not mentioned Simultaneous: 0 (0) | SO: 30 (100) | 27 (90.0) | 28 (93.3) | Not reported |
| Grigoropoulos, 2007, UK26 | 304 (302) | 20 (3-78) | 60 (4-94); 61.9 | CP: 190 (62.5) CA: 80 (26.3) Not documented: 34 (11.2) | Prior: 123 (40.5) Simultaneous: 6 (2.0) | SO: 300 (98.7) Gas: 4 (1.3) | 156 (51.3) | 219 (72.0) | Not reported |
| Quiram, 2006, US25 | 56 (56) | 25 (6-70) | 62 (19-87); 60.0 | CA: 56 (100) | Prior: 31 (55.4) Simultaneous: 18 (32.1) | SO: 45 (80.4) Gas: 11 (19.6) | 34 (60.7) | 52 (92.9) | Not reported |
| Tseng, 2005, US20 | 81 (80) | 20.6 (3-69) | 62.6 (27-92); 58.8 | CA: 65 (80.2) CP: 16 (19.8) | Prior: 62 (76.5) Simultaneous: 19 (23.5) | SO: 47 (58.0) Gas: 34 (42.0) | 65 (80.2) | 80 (98.8) | Intraoperative bleeding: 3 (3.7) Iatrogenic retinal break: 19 (22.5) Retinal dialysis: 3 (3.7) |
| Current study | 61 (61) | 21.4 (3-84) | 48.6 (18-76); 67.2 | CA: 49 (80.3) CP: 12 (19.7) | Prior: 6 (9.8) Simultaneous: 34 (55.7) | SO: 61 (100) | 45 (73.8) | 61 (100) | Intraoperative bleeding: 0 (0) Iatrogenic retinal break: 13 (21.3) |
n: Number, PVR: Proliferative vitreoretinopathy, SB: Scleral buckle, SO: Silicone oil, SF6: Sulfur hexafluoride gas, C3F8: Perfluorocarbon gas, CP: Proliferative vitreoretinopathy grade C posterior to the equator, CA: Proliferative vitreoretinopathy grade C anterior to the equator